JW Pharmaceutical Corp
KRX:001060
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
JW Pharmaceutical Corp
KRX:001060
|
KR |
|
J
|
Jollibee Foods Corp
XPHS:JFC
|
PH |
|
R
|
Reserve Petroleum Co
OTC:RSRV
|
US |
|
Fire & Flower Holdings Corp
TSX:FAF
|
CA |
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
IL |
|
A
|
Aclara Resources Inc
TSX:ARA
|
CL |
|
Stoneweg Europe Stapled Trust
SGX:SET
|
SG |
|
E
|
Empower Clinics Inc
CNSX:EPW
|
CA |
|
A
|
Alpha Metallurgical Resources Inc
NYSE:AMR
|
US |
|
K
|
Kolon Corp
KRX:002020
|
KR |
|
Taiyo Yuden Co Ltd
TSE:6976
|
JP |
|
Eventbrite Inc
NYSE:EB
|
US |
Bankruptcy Probability
JW Pharmaceutical Corp's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
JW Pharmaceutical Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
JW Pharmaceutical Corp
KRX:001060
|
733.5B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
JW Pharmaceutical Corp's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, JW Pharmaceutical Corp has total debt of 38.5B KRW. This includes both short-term (20B KRW) and long-term (18.5B KRW) debt.
You can find a full breakdown on its Balance Sheet.
